文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 医药卫生 > Study on Antithrombotic and Antiplatelet Activities of Low Molecular Weight Fucoidan from
侵权投诉

Study on Antithrombotic and Antiplatelet Activities of Low Molecular Weight Fucoidan from

Study on Antithrombotic and Antiplatelet Activities of Low Molecular Weight Fucoidan from Laminaria japonica

Study on Antithrombotic and Antiplatelet Activities of Low Molecular Weight Fucoidan from

J. Ocean Univ. China (Oceanic and Coastal Sea Research)

DOI 10.1007/s11802-012-1874-1

ISSN 1672-5182, 2012 11 (2): 236-240 doc.guandang.net E-mail:xbywb@ouc.edu.cn

Study on Antithrombotic and Antiplatelet Activities of Low Molecular Weight Fucoidan from Laminaria japonica

CHEN Anjin 1), 3), ZHANG Fang 3), SHI Jie 1), 3), and ZHAO Xue 2),*

1) School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, P. R. China 2) College of Food Science and Technology, Qingdao 266003, P. R. China

3) Qingdao Municipal hospital, No.1, Jiaozhou Road, Qingdao 266071, P. R. China

(Received September 30, 2011; revised October 9, 2011; accepted March 2, 2012)

© Ocean University of China, Science Press and Springer-Verlag Berlin Heidelberg 2011

Abstract The antithrombotic and antiplatelet effects of two fucoidan fractions with low molecular weight and different sulfate content from Laminaria japonica were compared in order to examine the influence of chemical character on their antithrombotic activity and the possible mechanism. Both LMW fucoidan fractions exhibited favorable antithrombotic activity in an Fecl3-induced arterial thrombosis. The antithrombotic activity of LMW fucoidan was related with decrease of TXB2 and whole blood viscosity and hematocrit. LMW fucoidan showed a correlation between anticoagulant, antiaggregant and antithrombotic effects in vivo. For LMW fucoidan, antithrombotic activity required high dose of 5-10 nmol kg-1, concomitantly with increase in anticoagulant activity and inhibition of platelet aggregation. Administration of LMW fucoidan significantly promoted the 6-keto-PGF1α content and decreased the TXB2 content, indicating its inhibition of tissue factor pathway and regulation of metabolism of arachidonic acid. By comparison, highly sulfated fucoidan LF2 with Mw 3900 seemed to be a more suitable choice for antithrombotic drug for its antithrombotic activ-ity accompanied with specific inhibitory activity on platelet aggregation, low anticoagulant activity and low hemorrhagic risk in vivo. Key words fucoidan; antithrombotic; coagulation; antiplatelet; hemorheology nantly related to the inhibition of thrombin activity by directly acting on the thrombin (Pereira et al., 1999) or to

1 Introduction the activation of thrombin inhibitors, including anti-Fucoidans represent an intriguing group of natural thrombin III and heparin cofactor II (Church et al., 1989; fucose-enriched sulfated polysaccharides from brown Mauray et al., 1995). Low molecular weight fucoidans

have been proposed as possible candidates for the treat-algae (Phaeophyta), sea cucumber (Echinodermata, Holo-thuroidea) and sea urchins (Echinodermata, Echinoidea). ment of cardiovascular diseases. However, the relation-It has been reported to exhibit potential pharmacological ship between chemical character and antithrombotic ac-actions in mammalian systems, such as anticoagulant, tivity in vivo of fucoidan from Laminaria japonica and antithrombotic, antimetastatic and antiviral activities possible mechanism are still unclear.

In our previous study, we have prepared fucoidan with (Pomin et al., 2008; Berteau et al., 2003; Cumashi et al.,

2007). As a consequence of the increasing incidence of various molecular weights and sulfated ester contents thromboembolic diseases, cardiovascular diseases are the from Laminaria japonica and revealed their antioxidant, leading cause of death (30% of total) in the world. Many hepatoprotective and anti-angiogenic activities (Zhao et

al., 2004, 2008; Matsubara et al., 2005). In the present studies have focused on the anticoagulant and antithrom-botic activity of fucoidan due to the pressing need for study, we obtained two low molecular weight fucoidan with acid extraction, ion-exchange chromatography, new antithrombotic drugs.

LMW fucoidan, especially fractions with molecular radical process degradation and ultrafiltration. Our objec-weight about 8kDa obtained by free radical degradation tive was to assess the effect of different fucoidan fractions from Ascophyllum nodosum, have been reported exerting on platelet aggregation, thrombosis formation, and blood antithrombotic effects on venous and arterial thrombosis, circulation and to provide pharmacological evidence for with significantly low hemorrhagic risk (Millet et al., their clinical application. 1999; Boisson-Vidal et al., 2000; Durand et al., 2008). However, the proposed mechanisms of anticoagulant ac-2 Materials and Methods

tivity of fucoidans from brown algae have been domi-

2.1 Ethnical Approval of the Study Protocol * Corresponding author. E-mail: chenanjin@sina.com The study protocol was approved by the Ethics Com-

第1页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email